Free shipping on all orders over $ 500

 About 1 result found for searched term "Monalizumab" (0.114 seconds)

Cat.No.  Name Target
M21501 Monalizumab Checkpoint
Monalizumab is a first-in-class immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab can be used in the study of head and neck squamous cell carcinoma (HNSCC).

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.